Bayosthiti
Molecular disease detection before symptoms
Bengaluru, Karnataka, India
India's first comprehensive molecular profiling and diagnostics company, a subsidiary of Houston-based Biostate AI Inc., making RNA sequencing and AI-based preventive healthcare affordable and accessible in India.
How We Help
Problem Statement
To solve the inaccessibility and unaffordability of advanced healthcare technologies in India by making RNA sequencing and AI-based preventive care affordable and accessible for the Indian population.
Core Technology
RNA Sequencing
Key Differentiators
India's first comprehensive molecular profiling and diagnostics company; Tailored for the Indian market and population; Patented Barcode-Integrated Reverse Transcription (BIRT) technology makes advanced RNA sequencing affordable; AI models trained on India-specific biological contexts
Clinical Focus
Precision cancer diagnostics
Company Info
- Business Model
- B2B
- Founded
- 2025
- Total Funding
- 20,000,000
- Website
- bayosthiti.ai/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Active 12,000-patient cardiac study with Narayana Institute of Cardiac Sciences; multi-institution collaborations; no published FDA approvals reported
MedStartr Index Score
?What do you think of Bayosthiti?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.